IMMUNOCHEMOTHERAPY WITH OBINUTUZUMAB OR RITUXIMAB IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA (FL) IN THE RANDOMIZED PHASE III GALLIUM STUDY: ANALYSIS BY CHEMOTHERAPY REGIMEN
Wolfgang Hiddemann, Anna Maria Barbui, Miguel Angel Canales Albendea, Paul K Cannell, Graham P Collins, Jan Dürig, Roswitha Forstpointner, Michael Herold, Mark Hertzberg, Magdalena Klanova, John A Radford, Kensei Tobinai, Alis Burciu, Günter R Fingerle-Rowson, Tina Nielsen, Marcel Wolbers, Robert E Marcus
Novinky z letošního nejvýznamnějšího evropského setkání hematologů 2017
Author(s): Wolfgang Hiddemann, Anna Maria Barbui, Miguel Angel Canales Albendea, Paul K Cannell, Graham P Collins, Jan Dürig, Roswitha Forstpointner, Michael Herold, Mark Hertzberg, Magdalena Klanova, John A Radford, Kensei Tobinai, Alis Burciu, Günter R Fingerle-Rowson, Tina Nielsen, Marcel Wolbers, Robert E Marcus Abstract: S 775 Session topic: 19. Indolent Non-Hodgkin lymphoma –...